DMD and Duchenne muscular dystrophy: In 2016, a study developed microengineered DMD model of skeletal muscle to assess the ability of human mesoangioblasts, compared to human myoblasts, in restoring dystrophin levels and distribution along the myotube when cocultured with myoblasts derived from DMD patients (Serena et al., 2016).